摘要
目的:通过测定原发性高血压患者、脑梗死患者外周血中CD40、CD40L以及血小板糖蛋白CD62P、CD63、PAC-1指标,探讨两者相关性,并为临床提供早期识别和预测的指标。方法:流式细胞术(FCM)检测CD40、CD40L以及血小板糖蛋白CD62P、CD63、PAC-1。结果:高血压患者、脑梗塞患者的CD40、CD40L表达明显增高以及血小板处于高度活化状态,并与梗死灶大小有一定的相关性,且CD40-CD40L与血小板糖蛋白呈明显正相关性。结论:高血压患者、脑梗死患者CD40、CD40L及血小板膜糖蛋白的测定,可作为高血压患者、脑梗死患者的病情监测和评价血栓前状态的一个有效指标。
Objective:To explore their correlation and supply a reference measure,we examination CD40, CD40L and platelet glycoproteins in hypertension patients and cerebral infraction patients. Methods: The expression of CD40, CD40L and CD62P, CD63, PAC -1 were measured by flow cytometry(FCM). Results:The expression of CD40, CD40L and platelet glycoprotein were higher in hypertension and cerebral infraction patients and were associated with infraction area. There was a remarkable correlation on CD40 - CD401 and platelet glycoprotein. Conclusion :The measurement of CD40, CD40L and platelet glycoproteins are very important for determination of clinical reference values in patient's condition development and early diagnosis of thrombus.
出处
《中国卫生检验杂志》
CAS
2009年第4期880-881,891,共3页
Chinese Journal of Health Laboratory Technology